Up­dat­ed: France draws €2B+ re­search, man­u­fac­tur­ing in­vest­ment from Sanofi, Pfiz­er, As­traZeneca, GSK

Sanofi, Pfiz­er and As­traZeneca sep­a­rate­ly pledged to in­crease their foot­print in France, with in­vest­ments adding up to al­most €2 bil­lion. GSK, Ab­b­Vie and No­var­tis are …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER